Cargando…
Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma
BACKGROUND: Malignant pleural effusion (MPE) comes generally with high mortality and poor prognosis. Recurrence of symptomatic MPE is always accompanied by poor survival quality. In lung adenocarcinoma, researchers speculate whether patients with actionable mutation or without are applicable to diff...
Autores principales: | Xu, Ke, Wu, Xiaodi, Chen, Lu, Xie, Jingyuan, Hua, Xin, Chen, Mo, Jiang, Yuxin, Liu, Hongbing, Zhang, Fang, Lv, Tangfeng, Song, Yong, Zhan, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579833/ https://www.ncbi.nlm.nih.gov/pubmed/37854163 http://dx.doi.org/10.21037/tlcr-23-151 |
Ejemplares similares
-
Development of RECLS score to predict survival in lung cancer patients with malignant pleural effusion
por: Zhang, Tianli, et al.
Publicado: (2021) -
Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion
por: Ai, Ling, et al.
Publicado: (2022) -
The diagnostic yield of closed needle pleural biopsy in exudative pleural effusion: a retrospective 10-year study
por: Zhang, Tianli, et al.
Publicado: (2020) -
Malignant pleural effusion from prostate adenocarcinoma
por: Knight, James C., et al.
Publicado: (2014) -
Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion
por: Li, Xinying, et al.
Publicado: (2021)